Parenteral

Parenteral designates drug administration routes bypassing the gastrointestinal tract through injection or infusion directly into body tissues or circulation, encompassing intravenous administration, subcutaneous injection, intramuscular injection, plus specialised routes including intradermal, intra-articular, intrathecal, or epidural delivery. These routes provide advantages including rapid onset, complete bioavailability, precise dose control, and enabling delivery of molecules with poor oral absorption including biologics.

Intravenous administration delivers drugs directly into systemic circulation achieving immediate therapeutic levels. Subcutaneous injection provides convenient self-administration for chronic treatments such as insulin and biologic immunosuppressants. Intramuscular injection enables larger volumes and depot formulations providing extended duration. Manufacturing requirements prove more stringent than oral dosage forms, requiring terminal sterilisation or aseptic processing, pyrogen testing, particulate matter control, and specialised container-closure systems. Formulation challenges include maintaining chemical and physical stability in aqueous solutions. As biologics dominate pharmaceutical innovation requiring parenteral delivery and device technology advances improving patient convenience through autoinjectors and pen devices, parenteral products continue representing critical drug delivery routes.